Possible breast cancer treatment unveiled

NEW YORK A team at the University of Missouri at Columbia has developed a promising new treatment for breast cancer, according to results presented in Baltimore Tuesday at the Department of Defense’s annual Era of Hope meeting on breast cancer.

The treatment combines a drug called PRIMA-1 and the monoclonal antibody 2aG4 to repair the mutated protein p53, which is found in half of the cases of breast cancer, and shut off new blood vessels that help provide energy to tumors.

Liang Yayun, who led the study, said the treatment “has complementary and potent anti-tumor activity and could define a new strategy for suppression of advanced breast cancers,” according to Reuters.